Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

GPs 'disgusted' by the CQC, prostate cancer drug to be more widely used and text messaging useful for medicine reminders

A round-up of the morning’s health news headlines

The BBC led its health news over the weekend with the repercussions from the CQC’s announcement that is was reviewing indicators.

It said that GPs were ‘disgusted’, and had told the BBC that their reputations had been ‘tarnished by incompetence’.

Sir Mike Richards, chief inspector of hospitals for the CQC, told the BBC that the regulator will make the practices who were wrongly categorised  ‘a big apology’. He added: ‘This only became apparent when we ran the data on the thousands of practices rather than just the hundreds that we tested them on.’

Over at the Daily Mail, a drug for advanced prostate cancer has been licensed for use earlier in the disease, limiting the need for chemotherapy

It reports that new datat shows that Enzalutamide can delay the need for chemotherapy by 17 months.

It cuts the risk of the disease progressing or death by more than three-quarters compared with ‘dummy’ treatment.

Finally, the BBC reports on a study showing that text messaging could help people remember to take the medicines they have been prescribed, say researchers.

A test scheme, which involved heart patients, cut the numbers who forgot or just stopped taking their pills.

One in six was helped to continue their treatment, reducing their risk of heart attack and stroke.

Have your say